This is a preview of subscription content, log in via an institution to check access.
Notes
antiretroviral
Reference
Garay OU, et al. Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM). PharmacoEconomics-Open : 9 Apr 2019. Available from: URL: https://doi.org/10.1007/s41669-019-0130-7
Rights and permissions
About this article
Cite this article
Lopinavir/ritonavir cost effective for HIV with viral suppression. PharmacoEcon Outcomes News 826, 17 (2019). https://doi.org/10.1007/s40274-019-5819-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5819-4